Introduction
Polymeric micelles (PMs) are nanoparticles composed of linear, synthetic monomers that contain several chemically distinct domains known as blocks. 1 Usually di-or triblock micelles are prepared, where the triblock variety may contain 1) a hydrophobic domain making up the core, 2) a handle domain that can be chemically functionalized, and 3) a hydrophilic domain that faces the surrounding aqueous medium (Figure 1) . Such monomers can self-assemble into nanostructures that can be engineered to exhibit a wide range of sizes (usually 5 -100 nm) and to be highly synthetically versatile. Polymeric micelles can accumulate in tumors through the enhanced permeation and retention (EPR) effect 2 and have potential as drug delivery systems, in particular by covalently binding drug molecules through labile bonds that can break at the desired site of action. 3, 4 The stability of polymeric micelles is in part determined by the critical micelle concentration (CMC). This number denotes the maximum concentration at thermodynamic equilibrium at which single monomers can exist freely in aqueous solution, and hence at which point they will start to form micelles. In circulation, polymeric micelles may disintegrate due to dilution below the CMC, as well as by interactions with blood-born proteins that shift the equilibrium towards the unimer state. 1 This causes possible release of drug molecules and the abrogation of the desirable nanoparticulate properties of the micelles. In order to circumvent this, the monomers of polymeric micelles have been crosslinked by a multitude of methods, in order to create an integral nanoparticle. These have included amide formation, 5 polymerization reactions 6, 7 , UV-induced initiator-mediated photo-crosslinking 8, 9 as well as more exotic methods. 10, 11 Reversible crosslinking strategies have been devised as a manner in which to control the release of cargo drug molecules, once accumulation at target sites has been achieved. This has been achieved using disulfide bonds, 12 cleavable imine linkages 13 and direct dimerization of core coumarin moieties through irradiation with ultraviolet light. 14 This latter strategy is known as photo core crosslinking (PCCL) and has the immediate advantage that no addition of reactive chemicals, initiators or purification steps are necessary. Coumarin undergoes 2+2 photodimerization to a cyclobutane ring when exposed to UV light of λ > 310 nm. If irradiated at λ < 260 nm, the ring is cleaved, refurnishing the two coumarin moieties as separate molecules. The chemical properties of coumarin as a reversibly dimerizable compound were excellently reviewed by Trenor et al. 15 and its applications by He et al. 16 As the crosslinkable carbon-carbon double bond of coumarin absorbs light around 320 nm, the degree of crosslinking can be assessed by measuring the drop in absorbance at this wavelength. As coumarin with a methyl group in the 4-position exhibits faster dimerization rates than other coumarin derivates 17 , 4-methyl coumarin is often employed in micelle crosslinking. 14, 18 When investigating crosslinking strategies, it is important to evaluate the stability of the resulting polymeric micelles against their non-crosslinked counterparts. As non-crosslinked PMs may have certain advantages, such as easier renal excretion and easier preparation, there is a rationale in not crosslinking unless the benefits are well-documented. A useful technique for investigating such key in vivo properties of nanoparticles is labeling with positronemitting radionuclides and imaging by positron emission tomography (PET). PET is based on the coincidence detection of positrons from positron-electron annihilation and is a truly quantitative technique which offers excellent sensitivity and spatial resolution. When imaging nanoparticles in murine models, an especially useful radionuclide is copper-64 ( 64 Cu, T ½ = 12.7 h), which offers an imaging window of up to 48-72 hours and thereby adequately covers the distribution phase of long-circulating PMs. Association of 64 Cu to nanoparticles is typically achieved by complexation in a covalently bound chelator molecule. The crossbridged, macrocyclic chelator 2,2'- (1,4,8,11-tetraazabicyclo[6.6.2] hexadecane-4,11diyl)diacetic acid (CB-TE2A) has been reported on several occasions to exhibit excellent serum and blood stream stability and is generally considered to be a highly reliable chelator for 64 Cu. 19, 20, 21 In the study at hand we employed in vivo PET imaging to investigate the difference in biodistribution between a crosslinked and a non-crosslinked version of two identical triblock coumarin-core polymeric micelles radiolabeled with 64 Cu through CB-TE2A. The CB-TE2A was conjugated to the middle block, where it would be shielded from interaction with in vivo components by the outermost polyethylene glycol (PEG)-layer, limiting the effects the chelate may have on the biodistribution of the micelles. 
Preparation of CB-TE2A conjugated polymeric micelles
The synthesis and micellization of CB-TE2A conjugated polyethylene glycolpolyhydroxyethyl methacrylate-polymethacryloyloxyethoxy-4-methylcoumarin (PEG-PHEMA-PCMA) unimers was carried out as previously reported by isolated macroinitiator atomic transfer radical polymerization (ATRP) (Figure 1) . 22 In brief, the PEG-PHEMA-Cl block copolymer was synthesized according to a literature procedure 23 and it was used as macroinitiator for the synthesisis of the 4-methylcoumarin block. The resulting triblock copolymer PEG-PHEMA-PCMA was precipitated from methanol and dried under vacuum.
Copper residues and residual impurities were removed by dialysis (molecular weight cut-off = 12 kDa). CB-TE2A was conjugated by ester bonds to the primary alcohols of the PHEMA block through 4-dimethylaminopyridine (DMAP)-catalyzed 1-ethyl-3-(3dimethylaminopropyl)carbodiimide (EDC) coupling in DMF. The micelles were subsequently formed by dialysis with water.
Crosslinking of micelles
Micelle dispersions (1100 µL) were transferred to a 4 mL glass vial which was placed in a water-ice bath kept at 5-7 o C. Under vigorous magnetic stirring, the dispersions were irradiated with UV light for 2 x 15 minutes at an intensity of 2 W/cm 2 and a wavelength of 320 < λ < 500 nm. The UV probe was placed above the water surface at a distance of about a centimeter. The degree of crosslinking (%CL) was determined by measuring the drop in absorbance (A) at 320 nm and calculating: ((A before − A after )/(A before -A 0 )) × 100% = %CL, where A 0 was set to zero. 24 
Radiolabeling
To a vial containing dried 64 CuCl 2 was added aqueous NH 4 OAc (100 µL, 0.1 M, pH 5.5), followed by magnetic stirring at room temperature for 10 minutes. Then was added crosslinked (CL) or non-crosslinked (nonCL) PM dispersions (400 µL, ~4 mg/mL) and the mixtures were stirred for 3 hours at 80 o C. After radiolabeling, non-incorporated 64 Cu was scavenged by immediate addition of aqueous EDTA (50 µL, 1 mM) followed by stirring for 20 minutes. The radiolabeled PMs were then separated from 64 Cu-EDTA by automated sizeexclusion chromatography using Sephadex 25 as stationary phase and isotonic PIPES buffer (10 mM PIPES, 150 mM NaCl, pH 7.0) as eluent. From the fractions making up the largemolecules peak (containing the PMs) a total volume of 1 mL which contained the highest concentration of radioactivity was collected and used for in vivo studies.
Characterization of micelles
Micelles were characterized by dynamic light scattering (DLS), providing hydrodynamic diameter, polydispersity index (PDI) and zeta-potential. Size was measured three times on the same sample, unless otherwise stated, and were reported as nr. weighted medians based on normal distributions. Zeta-potentials were measured by running 20 runs of 10 scans on one sample, unless otherwise specified. The concentration of micelle material in dispersion was determined by measuring absorption of UV light at 320 nm in non-crosslinked dispersions.
This value was compared to the absorption of dispersions that had been subsequently lyophilized to determine the amount of micelle material.
Formulation of 64 CuCl 2 for control experiment
To a vial containing dried 64 CuCl 2 was added a solution of NH 4 OAc in saline (2.3 mL, NH 4 OAc: 10 mM, NaCl: 150 mM, pH = 6.4). The mixture was magnetically stirred for 30 minutes at 55 o C and used for injection after cooling to room temperature.
In vivo PET/CT studies
All animal experiments were approved by the Danish Animal Welfare Council, Ministry of Environment & Food. Seven weeks old female NMRI nude mice purchased from Tarconic (Borup, Denmark) were inoculated in the right and left flank with 5*10 6 U87MG cells (LGC standards, Boras, Sweden) in a 1:1 mixture with matrixgel™ (BD Biosciences, Albertslund, Denmark). Tumors were allowed to grow for 2 weeks giving tumor sizes of 133 ± 79.9 mm 3 (mean ± SD). The mice were divided into three groups; CL (n = 6) nonCL (n = 5) and free 64 Cu (n = 5). The CL group has previously been published. 22 Either of the three solutions were intravenously injected in a lateral tail vein of anesthetized mice at an average dose of The statistics were calculated using Excel 2010. Differences between groups were analyzed using an unpaired, two-tailed t-test.. A p-value < 0.05 was considered significant. Error bars on tracer accumulation (%ID/g) are presented as standard deviations (SD).
Preparation of radiolabeled micelles
As previously described, about 5% of the PEG-PHEMA-PCMA monomers were conjugated with CB-TE2A. 22 From these monomers, micelles were formed by dialysis. One single batch was prepared for in vivo studies, and this was split into two parts, where one was crosslinked by UV irradiation. For this reason, the only difference between the crosslinked (CL) and noncrosslinked (nonCL) micelles, apart from slight differences in radiolabeling yield, would be the crosslinking. Successful crosslinking of the CL micelles was tested by measuring the drop in UV-absorbance at 320 nm, giving a degree of crosslinking (%CL) of 45% (Figure 2) . In The CL and nonCL micelles were radiolabeled with 64 Cu under identical circumstances with heating to 80 o C for 3 hours. Higher temperatures (95 o C) had been observed to cause aggregation of the micelles, and since 80 o C has previously been reported for 64 Cu-labeling of CB-TE2A this temperature was used. 19 After incubation with 64 Cu, unincorporated radioactivity was scavenged by adding EDTA. EDTA (logK: 18.5) is a relatively weak chelator of Cu 2+ , but takes it up efficiently at room temperature. Scavenging is necessary as free 64 Cu is known to accumulate in both tumors and liver, 25 which are also intrinsic properties of nanoparticles. 22, 26 We had previously incubated PEG-PHEMA-PCMA monomers with no CB-TE2A with 64 Cu for 3 hours at 80 o C and found that 17% of the radioactivity was associated with the micelles without EDTA scavenging, whereas 8% was associated after EDTA scavenging. It can be assumed that this number is lower with CB-TE2A conjugated micelles, as a large amount of the 64 Cu will be taken up by the chelator.
After EDTA scavenging, the radiolabeling efficiencies were, CL: 47% and NonCl: 40%. The micelle material concentrations upon injection were around 1.0 mg/mL for both micelle types with corresponding specific radioactivities (at injection) of 40-45 MBq/mg.
In vivo PET/CT studies
Both CL and nonCL versions of the 64 Cu radiolabeled micelles were injected into the tailveins of tumor-bearing mice, followed by in vivo monitoring using PET/CT (Figure 3) .
Organ specific accumulation was quantified (Figure 4) . Blood concentrations for both micelle types showed relatively long circulation times, with circulation half-lives on the order of 20 hours. Accordingly, the nonCL micelles were also long-circulating. At the 1 h time point (CL: 21.7 ± 4.2 %ID/g, nonCL: 18.4 ± 1.2 %ID/g), no statistically significant difference between the blood concentrations of CL and nonCL was observed (p = 0.116), but the tendency for lower blood concentration for nonCL became significant at 22 h (p = 0.016) and 46 h (p = 0.004). However, this difference was not supported by the ex vivo data measured at 48 h after injection (Figure 5) , where no significant difference was observed between the blood concentrations of CL and nonCL (CL: 4.2 ± 0.8 %ID/g, nonCL: 4.0 ± 0.4 %ID/g, p = 0.464). That a significant difference was observed only in the PET/CT images may be a consequence of the small size of the left ventricle, where partial volume effects could have influenced the PET readings. Consequently, it is reasonable to conclude that the two PM types followed similar courses of elimination from blood, with minor differences. Looking at the remaining organs, no significant differences between CL and nonCL were observed for liver, while all three measurement times showed significantly higher accumulation in spleen for CL compared to nonCL (p < 0.001). In the kidneys, only t = 22 h was significantly different (p = 0.020), while muscle and tumor had p-values above 0.05 for all measuring times. A similar picture was observed in the ex vivo data, where only tumor (p = 0.023) and spleen (p = 0.005) showed significant difference. Accordingly, our data suggests limited differences between the biodistributions of CL and nonCL, indicating that no pronounced advantage is obtained from crosslinking this type of PM. Although the data may hint at a marginally higher renal clearance for the nonCL PMs, this seems to hold little practical relevance for circulation times and tumor accumulation. The high stability of the nonCL micelles may be related to the coumarin moieties forming glassy cores with high kinetic stability.
In order to ensure that the observed similarity between the two micelle types was not simply a consequence of loss of 64 Cu from the PMs, control experiments using 64 Cu were carried out. 64 CuCl 2 was injected as a non-buffered saline solution (pH = 6.5) in which the 64 Cu was stabilized in solution by ammonium acetate, in order to limit the formation of 64 Cu-containing nanocolloids. Pronounced differences between the biodistributions of the free 64 Cu and the PMs were observed. From the PET data (Figure 4) a fast elimination of the 64 Cu from the circulation was observed (1 h = 3.0 ± 1.0 %ID/g), followed by a plateau concentration around 2-3 %ID/g. This indicated that the 64 Cu was quickly taken up by the organs, followed by serum trafficking on copper-carrying proteins, notably albumin and ceruloplasmin. 27 As mentioned above, significantly slower elimination of the PMs from the circulation was observed. The primary accumulation organ for Cu is the liver, 27, 28 which was also observed for free 64 Cu in our data, at a level that was significantly greater than for the PMs (1 h = 15.7 ± 1.2 %ID/g). That the 64 Cu associated with the PMs was not cleared as rapidly and did not exhibit such high liver accumulation, supports that the 64 Cu was bound to the micelles in both cases. The initial accumulation of the free 64 Cu was followed by redistribution/elimination from the liver resulting in a drop in liver values that was faster than for the PMs. Splenic accumulation was limited for the free 64 Cu and significantly lower than for the PMs. Since substantial splenic accumulation of nanoparticles is routinely observed, 29 this observation also supports that the 64 Cu was bound to the PMs. Interestingly, free 64 Cu showed kidney accumulation similar to the PMs. 64 Cu has previously been observed to accumulate in kidneys. 25 Further, 64 Cu has also been reported to independently accumulate in tumors, 25 possibly since Cu plays a role in tumor angiogenesis, 30 which we also observed in this study.
The tumor accumulation of free 64 Cu was comparable to the micelles, but in contrast to the PMs which showed a steady accumulation, the 64 Cu showed high initial accumulation (1 h = 4.4 ± 1.8 %ID/g), followed by a slight, though statistically insignificant, drop in values.
In summary, it appears that the nonCL micelles exhibit excellent stability in circulation, in spite of the lack of crosslinking, resulting in circulation times that are on par with the crosslinked variant. It is often assumed that crosslinking improves the pharmacokinetic profile of polymeric micelles by making them longer circulating and thereby enhancing tumor accumulation by the EPR-effect. In this study, we showed that this is not always the case in an in vivo setting, at least for 4-methylcoumarin based systems. It should be noted that the unimers employed here only contained 18 repeats of the 4-methylcoumarin unit and the stabilizing lipid domain was thus relatively short. We also demonstrated the usefulness of PET imaging when investigating the in vivo effect of modifications to polymeric micelles, such as crosslinking. The results presented here are interesting since the presence of single unimers without crosslinking is often preferable to cross-linked micelles, provided that the micelles exhibit sufficient kinetic stability in circulation. As the threshold for renal clearance is < 10 nm, 31 single unimers are more easily cleared than crosslinked micelles, requiring only disintegration, rather than chemical degradation. Although coumarin-containing micelles can be de-crosslinked by light exposure, UV light cannot reach deep tissues, and is therefore generally not useful for micelle de-crosslinking after organ accumulation in the clinical setting. 32 Slow clearance of therapeutically administered crosslinked polymeric micelles can potentially result in accumulation of nanoparticulate material with so far poorly understood consequences. In addition, much recent methodology is based on disintegration of micelles as a response to pH changes. 33 Such methods can only be used if the unimers are held together by relatively weak hydrophobic interactions and the breaking of chemicals bonds from crosslinking is not required. Finally, we observed that the crosslinking step can confer some instability to the PMs if not carefully controlled, making it preferable to totally omit this step, especially when scaling up the manufacturing process.
Conclusions
In this study we compared the in vivo biodistribution of non-crosslinked polymeric micelles containing a core consisting of 18 repeats of 4-methylcoumarin with their crosslinked counterparts. The biodistributions of the two micelle types showed limited differences that can be considered negligible in a nanomedicine context. This was demonstrated against control injections of free 64 Cu, which showed substantial tumor accumulation but differed markedly from the micelles in key organs, notably liver and spleen, as well as bloodstream concentrations. These findings are significant in that omitting crosslinking is often preferable in drug delivery due to easier clearance, less cumbersome preparation and more freedom in release strategies. Further, the demonstrated methodology showcases a general nuclear imaging technique that can be utilized for in vivo investigation of micelle stability for a range of PM types. 
